ImmunoTherapeutics Inc said Tuesday it has named Michael Rosen president and chief executive, effective immediately.
Rosen replaces Gerald Vosika, who will continue as the company's chairman and chief scientific officer.
Prior to joining ImmunoTherapeutics, Rosen was president and chief executive officer of Pharma Mar SA.
--Chicago newsdesk, 312-408-8787